Advertisement
  • Loading metrics

Enhanced Protective Efficacy of a Chimeric Form of the Schistosomiasis Vaccine Antigen Sm-TSP-2

  • Mark S. Pearson,

    Affiliation Queensland Tropical Health Alliance and School of Public Health and Tropical Medicine, James Cook University, Cairns, Queensland, Australia

  • Darren A. Pickering,

    Affiliation Queensland Tropical Health Alliance and School of Public Health and Tropical Medicine, James Cook University, Cairns, Queensland, Australia

  • Henry J. McSorley,

    Affiliation Queensland Tropical Health Alliance and School of Public Health and Tropical Medicine, James Cook University, Cairns, Queensland, Australia

  • Jeffrey M. Bethony,

    Affiliation Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington D.C., United States of America

  • Leon Tribolet,

    Affiliation Queensland Tropical Health Alliance and School of Public Health and Tropical Medicine, James Cook University, Cairns, Queensland, Australia

  • Annette M. Dougall,

    Affiliation Queensland Tropical Health Alliance and School of Public Health and Tropical Medicine, James Cook University, Cairns, Queensland, Australia

  • Peter J. Hotez,

    Affiliation Department of Pediatrics and Molecular Virology and Microbiology, and National School of Tropical Medicine, Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine, Houston, Texas, United States of America

  • Alex Loukas

    alex.loukas@jcu.edu.au

    Affiliation Queensland Tropical Health Alliance and School of Public Health and Tropical Medicine, James Cook University, Cairns, Queensland, Australia

Enhanced Protective Efficacy of a Chimeric Form of the Schistosomiasis Vaccine Antigen Sm-TSP-2

  • Mark S. Pearson, 
  • Darren A. Pickering, 
  • Henry J. McSorley, 
  • Jeffrey M. Bethony, 
  • Leon Tribolet, 
  • Annette M. Dougall, 
  • Peter J. Hotez, 
  • Alex Loukas
PLOS
x

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.